
Piramal Pharma Limited has informed the Exchange regarding a press release dated January 22, 2025, titled "Press Release Piramal Critical Care Announces U.S. Launch of ChlorpromazineHydrochloride for Injection, USP".
Filed with NSE ·

Piramal Pharma Limited has informed the Exchange regarding a press release dated January 22, 2025, titled "Press Release Piramal Critical Care Announces U.S. Launch of ChlorpromazineHydrochloride for Injection, USP".
6ix hasn’t read this filing yet.
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma